HomeSIGA • NASDAQ
SIGA Technologies Inc
add
$5.50
0.36%
After Hours:(0.00%)0.00
$5.50
Closed: Apr 2, 4:41:36 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 81.47M | -30.06% |
Operating expense | 6.91M | -6.43% |
Net income | 45.76M | -36.67% |
Net profit margin | 56.17 | -9.45% |
Earnings per share | — | — |
EBITDA | 57.22M | -37.68% |
Effective tax rate | 21.89% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 155.40M | 3.50% |
Total assets | 244.34M | -3.94% |
Total liabilities | 28.53M | -50.37% |
Total equity | 215.80M | — |
Shares outstanding | 71.44M | — |
Price to book | 1.81 | — |
Return on assets | 64.92% | — |
Return on capital | 73.54% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 45.76M | -36.67% |
Cash from operations | 56.31M | -28.75% |
Cash from investing | -17.84K | — |
Cash from financing | -161.76K | — |
Net change in cash | 56.13M | -28.98% |
Free cash flow | 45.35M | -32.60% |
Previous close
$5.48
Day range
$5.36 - $5.51
Year range
$5.16 - $12.83
Market cap
392.90M USD
Avg Volume
486.25K
P/E ratio
6.68
Dividend yield
-
Primary exchange
NASDAQ
About
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications. Wikipedia
CEO
Founded
Dec 28, 1995
Website
Employees
46
